The influence of docetaxel schedule on treatment tolerability and efficacy in patients with metastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials

BACKGROUND: Administration of single-agent docetaxel in a weekly schedule may offer similar efficacy, with a more favorable toxicity profile, compared to a three-weekly schedule in patients with metastatic breast cancer. METHODS: The original search of Medline, Embase, and Scopus was performed in Se...

Descripción completa

Detalles Bibliográficos
Autores principales: van Eijk, Maarten, Vermunt, Marit A. C., van Werkhoven, Erik, Wilthagen, Erica A., Huitema, Alwin D. R., Beijnen, Jos H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788086/
https://www.ncbi.nlm.nih.gov/pubmed/35078455
http://dx.doi.org/10.1186/s12885-022-09196-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788086/
https://www.ncbi.nlm.nih.gov/pubmed/35078455
http://dx.doi.org/10.1186/s12885-022-09196-x

Ejemplares similares